through 'in-bone micro-pharmacies' targeting compromised bone biology
JWP GmbH is transforming orthopedic surgery by creating 'in-bone micro-pharmacies', a platform that combines localized disease control with active bone regeneration — eliminating the current costly standard of care consisting of 2-stage surgeries and replacing it with 1-stage treatment.
We merge cutting-edge nanomedicine and pharmacological technologies with clinically proven allograft biology to redefine orthopedic surgery.
~$0B
Total Addressable Market (TAM)
~$0B
Serviceable Available Market (SAM)
0+
US / EU new patients annually
~6% CAGR across 10 orthopedic indications
Partnered with Aachen University Hospital for prototype development
Collaborating with Prof. Dr. Dr. Twan Lammer's group to advance drug-eluting bone graft prototypes.
15 December 2025
1st Place at BioRiver Boost Competition
Winner of the 12th BioRiver Boost, one of Germany's premier industry-led Biotech/MedTech StartUp competitions.
11 December 2025
Top Prize at ZEBRA Accelerator
Awarded Top Prize in the Investment MasterClass category at the ZEBRA Accelerator program.
04 December 2025
State Innovative Entrepreneurs Grant Award
Dr. Wa'el Al Rawashdeh awarded the prestigious State Innovative Entrepreneurs Grant to accelerate development of our regenerative technologies.
01 October 2025